Uterine fibroids are the most common reproductive tract tumor and are prevalent in up to 80% of women by the age of 50 1 Communicating the relationship of fibroids to the mucosal and serosal surfaces of the uterus is important for several reasons. Women with symptomatic fibroids diagnosed before completing child-bearing who elect to undergo uterine-conserving treatment are focused on the impact of treatment on fertility. These risks are impacted by the degree of fibroid extension into the myometrium. For intramural fibroids, transmural incisions carry a higher risk than removing pedunculated fibroids, and can influence whether the procedure can be completed laparoscop-
| INTRODUCTION
Uterine fibroids are the most common reproductive tract tumor and are prevalent in up to 80% of women by the age of 50 1 Communicating the relationship of fibroids to the mucosal and serosal surfaces of the uterus is important for several reasons. Women with symptomatic fibroids diagnosed before completing child-bearing who elect to undergo uterine-conserving treatment are focused on the impact of treatment on fertility. These risks are impacted by the degree of fibroid extension into the myometrium. For intramural fibroids, transmural incisions carry a higher risk than removing pedunculated fibroids, and can influence whether the procedure can be completed laparoscop-
ically or requires open surgery. Likewise, the risk of hysteroscopic myomectomy also increases when fibroids extend deeper into the myometrium. Moreover, a comparable classification system for fibroid uteri is also needed for research studies.
The International Federation of Gynecology and Obstetrics (FIGO)
classification system for abnormal uterine bleeding is intended to help both clinicians and researchers better categorize the causes of bleeding and plan treatments. [2] [3] [4] [5] Prior to the institution of the FIGO abnormal uterine bleeding nomenclature, there was substantial misunderstanding in terminology and regional variation in nomenclature. 1 A classification system for submucosal fibroids that reported the relationship of the fibroid to the mucosal surface of the uterus was introduced earlier than 20 years ago by Wamsteker et al. 6 and was later adopted by the European Society for Gynaecological Endoscopy.
FIGO adopted and extended this classification system to all fibroids in the uterus by describing the relationship of fibroids to both the serosal and mucosal uterine surfaces. 5 The FIGO classification system 5 retains the original submucosal relationship of types 0-2, but extends staging to an additional six categories. Type 3 fibroids abut the endometrium but are completely intramural. Type 4 describes a completely intramural fibroid; types 5 and 6 are defined by the relationship to the serosal layer; type 7 describes fibroids that are pedunculated on the sub-serosal surface;
and type 8 refers to fibroids found in ectopic locations such as the cervix. Additionally, FIGO staging allows a range of stages if the fibroid traverses multiple layers; for instance, a fibroid with less than half of its volume in the uterine cavity and extending to the sub-serosal layer could be labeled type 2-5.
The FIGO PALM-COEIN method is being adopted internationally.
However, the limitations of real-world use of this fibroid classification system are not well described in the literature. 7 The present study was focused on the application of the FIGO anatomic uterine fibroid classification system in clinical practice.
| MATERIALS AND METHODS
The present retrospective cohort study enrolled women who pre- 
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for inter-reader and intra-specialty agreement. Statistical analyses were performed using STATA version 12.1 (StataCorp, College Station, TX, USA) and P≤0.05 was considered statistically significant.
| RESULTS
There were 25 patients who presented for treatment of uterine fibroids who had complete MRI examination details available from the study period. After MRI, one patient was excluded owing to having only adenomyosis, and another had a severe motion artifact that made the MRI results unreadable. Consequently, 23 women were included in the analysis; five had only one fibroid evaluated, 17 had two fibroids staged, and one patient had three fibroids included, comprising a total sample of 42 fibroids ( Of the 42 fibroids, 36% (15) had staging discrepancies that could impact surgical management and 64% (27) had fibroid-staging discrepancies that were determined as not having clinical implications.
Examples of staging discordance that would affect surgical management are shown in Figures 1 and 2 . Figure 3 illustrates an example of discordant staging that would likely not change the clinical management of the larger fibroid despite this fibroid having four unique classifications; the management of the smaller fibroid would be slightly affected.
The fibroid volume affected the classification of fibroids (Fig. 4) . The highest staging discrepancy occurred for fibroid 7A; two physicians labeled it as type 0, one classified it as type 8, and one classified it as type 2-5 (Fig. 5) . Following staging, the experts concluded after discussion that both type 0 and type 8 were correct because it was a pedunculated fibroid in the cervix. Both pieces of information were important for the management of this tumor; this consisted of hysteroscopic and manual resection of a prolapsing fibroid.
In the sensitivity analysis that accounted for the range of stages, 
| DISCUSSION
The FIGO system has advanced the level of standardization in evaluating abnormal uterine bleeding. However, based on the present study, additional validation of the FIGO fibroid classification system appears to be indicated for both clinical and research use. The application of FIGO staging was not consistent across physicians in the present study and this was not related to physician specialty.
A larger fibroid volume was also associated with more classification discrepancies; larger fibroids could have distorted uterine landmarks, making it difficult to determine the extent of myometrial invasion.
Of the fibroids classified, 36% had staging differences that would have had a substantial impact on surgical planning. These tumors were significantly smaller; smaller tumors could be more difficult to stage accurately, and the significance of a small fibroid-classification discrepancy could be less important when there are multiple fibroids in the uterus. The other fibroids could already increase surgical risks or could change surgical planning. Of the surgical outcome data available, MRI was helpful in surgical planning but MRI was imprecise in classification.
It could be argued that, despite previous classification by a radiologist, a surgeon would review the images and the discrepancy (as shown in Fig. 1) would not impact surgical management as a result.
However, this type of classification discrepancy is important for F I G U R E 1 In fibroid 12A, a typical T2 dark fibroid arising from the posterior uterine wall extends into the uterine cavity inferiorly, distorting the serosa. Fibroid 12A was classified as type 2, type 4, and type 3-6.
F I G U R E 2
In fibroid 6A, a fibroid arising from the posterior wall impacts the uterine cavity. It is almost exactly 50% intramural from a sagittal view (A). It appears to be <50% intramural using a coronal view (B). With an axial view, it appears to be >50% intramural (C).
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research studies where classification could be an independent variable for the comparison of outcomes. Therefore, a type-2 label for a fibroid could be insufficient in explaining the outcome of an abdominal myomectomy rather than a hysteroscopic myomectomy compared with other hysteroscopically resected type-2 fibroids. Limitations to the FIGO classification system should be described and researchers should consider combining categories for studying outcomes. Also, the addition of a fibroid location outside the uterine body, such as a cervical fibroid (type 8), is an important factor in planning; ectopic location could have more value as an additional descriptor rather than a separate category.
In the present study, MRI was chosen for clinical evaluation because most of the patients had multiple or large fibroids. MRI is considered better able to distinguish fibroids than ultrasonography if there are more than four fibroids or if the uterus is larger than 375 cm. 8 MRI is the modality selected for fibroid mapping in the fibroid clinic prior to focused ultrasound ablation or myomectomy. However, similar validation using ultrasonography is also indicated given its widespread use worldwide for fibroid diagnosis and management.
Physicians with lengthy fibroid-treatment experience performed the staging in the present study; all physicians were part of the Fibroid Clinic, a referral center at a large academic medical center. Each physician reviewed the FIGO sub-classification system and used the fibroid map to define classifications. 5 The four physicians perform uterineconserving procedures for women of reproductive age and are aware of the risks of misdiagnosing fibroid stage. The risks of misclassifying fibroids for focused ultrasound ablation surgery include incidentally ablating a stage 0 or 1 fibroid that would subsequently pass through the cervix, causing pain or infection. Similarly, performing a laparoscopic myomectomy on a fibroid that extended further into the myometrium than expected would increase the risk of adhesions or subsequent uterine rupture from transmural incisions. 9, 10 The staging for the present study was performed in the same way it would be for clinical care and the study center.
The present study was not without limitations. All women included in the study were seeking treatment owing to significant fibroid symptoms and underwent MRI for uterine-conserving treatment options. These recruitment restrictions likely limit the generalizability of the present study for women with fewer and/or smaller fibroids, or women seeking hysterectomy who do not require MRI.
Although staging fibroids is an ideal goal, the number of different intended, consensus was difficult. Attempting a strict classification could F I G U R E 3 Fibroid 11A is the larger fibroid arising from the posterior uterine wall compressing the uterine cavity and extending to the serosa; it was classified as type 3, type 4, type 3-5, and type 4-5. 11B is the smaller T2 dark subserosal fibroid with possible extension into the myometrium; it was classified as type 6 and type 7. misguide surgical procedures and make comparative research inaccurate. Further studies would benefit from reviewing the outcomes of surgery by classification or confirmation of staging by second modalities.
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